Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Research
New Research Published on Generic Competition
As the FDA looks to boost generic competition, a new working paper published by the National Bureau of Economic Research…
US Senate Passes FDA User Fees, Right to Try and Opioid Legislation
After many months of debate, both chambers of Congress passed the FDA User Fee Package. This comes after the Senate passed its…
PhRMA Report Shows More than 240 Immuno-Oncology Treatments in Development
In early June 2017, the Pharmaceutical Research and Manufacturers of America (PhRMA) – in partnership with the American…
FDA Drug Approvals on an Uptick
Already in 2017, the FDA has approved a number of new drugs, which Regulatory Focus points out as a trend away from the low number…
Dr. Stossel Corrects a Common Misconception
Thomas P. Stossel, MD, MD (Hon), is a visiting scholar at the American Enterprise Institute and professor emeritus at Harvard…
JAMA: Research Parasites Wanted
As reported, earlier this year, a top medical journal ignited a backlash by referring to "research parasites", also…
The Importance of Private Investment into Research and Development
Recently, we covered Thomas Stossel, M.D.’s new book, Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical…
Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical…
Long a champion of physician and industry collaboration, Thomas Stossel, M.D., has published a new book entitled …
A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate…
Developing a new prescription medicine that gains marketing approval is estimated to cost drugmakers $2.6 billion according to a…
Clinical Trial Transparency Update: Eli Lilly, Bayer, Boehringer, and BMS…
Eli Lilly, Bayer Healthcare, and Boehringer Ingelheim have announced their plans to increase access to their clinical trial…